SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-17-203493
Filing Date
2017-06-14
Accepted
2017-06-14 16:05:33
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d405856dsc13da.htm SC 13D/A 41503
  Complete submission text file 0001193125-17-203493.txt   43026
Mailing Address 4275 EXECUTIVE SQUARE SUITE 650 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 650 LA JOLLA CA 92037 858-373-1500
MEDICINOVA INC (Subject) CIK: 0001226616 (see all company filings)

IRS No.: 330927979 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-81409 | Film No.: 17911215
SIC: 2834 Pharmaceutical Preparations

Mailing Address 19-48, YOSHINO, MATSUMOTO-CITY NAGANO-PREFECTURE M0 399-8710
Business Address 19-48, YOSHINO, MATSUMOTO-CITY NAGANO-PREFECTURE M0 399-8710 81-3-3279-2307
Kissei Pharmaceutical Co., Ltd. (Filed by) CIK: 0001532923 (see all company filings)

IRS No.: 000000000 | State of Incorp.: M0 | Fiscal Year End: 0331
Type: SC 13D/A